What is needed is a transformation in clinical research and treatment to enable sex and gender precision medicine, says Dr. Antonella Santuccione Chadha, Ph.D., CEO and cofounder of the Women’s Brain Foundation. “As more drug developers start to understand the huge opportunity around women’s health, we’re going to get better drugs.” 

Published June 14, 2024 | By Ben Comer, Chief Editor Life Science Leader

Leave a Reply

Your email address will not be published. Required fields are marked *